At a glance
ClinicalIndex Comparison RecordN/ACompleted· 170 enrolled
Drug / intervention
Textingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of a Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetic Patients (SAMI TRIAL)
In Brief
A clinical study evaluating Texting for Diabetes. Completed, enrolled 170 participants across 3 sites.
Detailed Summary
The purpose of this study is to determine the impact of two-way short message service (SMS) on glycemic control in low-income, poorly-controlled adult diabetic patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
First PostedJan 2014
Primary CompletionMar 2016
TodayJul 2026
First PostedJan 30, 2014
Enrollment StartJan 1, 2014
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 12.4 years ago
Interventions
Textingother
Bidirectional texting once weekly for 12 weeks